eli lilly pill glp 1 US approves new oral weight-loss developed by | US news Foundayo gains FDA approval as
Description
2024;51(1) doi: 10.1007/S11033-024-09793-Y
Neuron , 109 (3), 461-472
The medication slows down the movement of food through the intestine and how quickly your stomach digests food
Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus
This data proves valuable for practitioners managing patients who frequently discuss medication tolerability concerns on platforms like Reddit, specifically for those who are non-responders to GLP-1
